Behavioural signals
Structured inputs and observed patterns that support clearer clinical review.
Solutions
Multimodal intelligence for clinical assessment.
SIPL’s solutions combine behavioural, physiological, genomic, pharmacogenomic, and clinical data streams to support structured clinical review.
Why single-modality assessment is not enough.
Mental and nervous system disorders are among the most complex phenomena in biology. Single-modality systems miss information. LifeBack™ combines multiple biological and behavioral signal streams to generate richer clinical evidence.
No single biomarker — genetic, acoustic, linguistic, or behavioural — is sufficient to characterise the complexity of serious mental illness or nervous system disorders. SIPL's research philosophy is fundamentally integrative. We pursue signal across modalities because that is where the biological truth lies — in the convergence of evidence, not the loudness of any single channel.
LifeBack™: clinical intelligence across modalities.
LifeBack™ is SIPL’s multimodal neurobiomarker platform, designed to transform how mental and nervous system disorders are assessed, diagnosed, treated, and prevented through objective, actionable intelligence.
Through LifeBack™, SIPL fuses genomics, behavioural signals, pharmacogenomics, and clinical data into objective, actionable intelligence — validated in live hospital conditions under ICMR-compliant ethical oversight, and built to work within the real constraints of the Indian healthcare system.
Genomic context
Biological variation and pharmacogenomic information interpreted alongside the whole patient story.
Clinical data streams
Patient history, longitudinal context, and evidence-linked outputs organized for professional judgement.
From screening to clinical review.
Step 1
Screening
LifeBack™ captures structured inputs across behavioural, physiological, genomic, pharmacogenomic, and clinical data streams.
Step 2
Analysis
AI-assisted systems synthesise multimodal signals into structured clinical intelligence.
Step 3
Insights
LifeBack™ surfaces longitudinal patterns, pharmacogenomic interactions, contraindications, probabilistic risk scores, and evidence-linked outputs.
Step 4
Clinical Review
Clinicians interpret findings within the full human story of the patient, exercise judgement, and make final diagnostic and treatment decisions.
The clinician is not a user interface between the AI and the patient. The clinician is the clinician. The AI is the instrument.